Find information about upcoming and past events.
BioCanRx webinar: An Introduction to Biologic GMP Manufacturing: Preparing for Early-Phase Clinical Trials
Dates: November 20, 27, and December 4, 2023
Location: Online
Register Here
SCN, BioCanRx, and the National Research Council of Canada are pleased to launch a three-part virtual training series: “An Introduction to Biologic GMP Manufacturing: Preparing for Early-Phase Clinical Trials.”
Held over three sessions, this virtual event is designed to give biomedical research teams a comprehensive understanding of the key topics in clinical translation, particularly progressing a therapeutic to GMP manufacturing for an early-phase clinical trial. The three sessions will cover crucial topics such as: critical decision-making points for bringing a product from an academic lab into GMP manufacturing/early phase clinical trials; preparing a preclinical data package for regulatory approvals; and engaging with contract development and manufacturing organizations (CDMOs).
Whether you are a seasoned researcher or just starting out, this event is an excellent opportunity to gain practical GMP manufacturing insights and knowledge to advance your research program and transition a new therapeutic to a GMP environment. The series will focus on early-phase clinical trials for biologics. This webinar series is a precursor to a larger in-person workshop-style event that is scheduled to take place in 2024.
Town Hall
On April 5, 2023, Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH) hosted a virtual CIEBH Town Hall to share information about Stage 2 of the Canada Biomedical Research Fund and Biosciences Research Infrastructure Fund (CBRF-BRIF) competition to date and details on the CIEBH expression of interest (EOI) process. The town hall featured an information session and a live Q&A period.
Watch the recording
Watch the recording of the information session portion of the town hall.
View the presentation slides
View the presentation slides (PDF) from the town hall: English | Français
Please refer to the expressions of interest page for the latest updates.